David Cucchiari
Overview
Explore the profile of David Cucchiari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ortiz F, Marson L, Thomas R, Kousios A, Rista E, Lefaucheur C, et al.
Transpl Int
. 2025 Mar;
38:14024.
PMID: 40078501
Kidney donation is a safe procedure for carefully screened donors. The growing shortage of organs and improved survival rates among recipients of living donor transplants have broadened the criteria for...
2.
Sellares J, Casanova F, Perez-Saez M, Cucchiari D, Coloma A, Vila A, et al.
Transplantation
. 2025 Feb;
PMID: 40020163
Background: Peripheral blood biomarkers aim to noninvasively diagnose kidney allograft rejection, but most lack robust independent validation. TruGraf is intended to exclude subclinical cellular rejection (TCMR), whereas donor-derived cell-free DNA...
3.
Olle J, Larque A, Fernandez de Larrea C, Diekmann F, Cucchiari D
J Nephrol
. 2025 Jan;
PMID: 39806131
There is no established treatment for late or chronic antibody-mediated rejection of a kidney graft. Rituximab-based treatment is not effective, since long-lived high-affinity plasma cells do not express CD20 and...
4.
Cucchiari D, Podesta M, Ponticelli C
Expert Rev Clin Immunol
. 2024 Oct;
20(12):1471-1481.
PMID: 39467249
Introduction: Rejection remains a major obstacle to successful kidney transplantation. The complex pathophysiology of rejection depends on a fine-tuned interplay between the innate and adaptive immune systems. Areas Covered: This...
5.
Arana C, Hermida E, Rovira J, Caro J, Cucchiari D, Larque A, et al.
Nephrol Dial Transplant
. 2024 Sep;
40(3):577-587.
PMID: 39257033
Background: Renal transplant recipients with donor-specific anti-HLA antibodies are at an increased risk of antibody-mediated rejection (ABMR). Early protocolized renal biopsies may serve as a strategy to improve diagnosis in...
6.
Cuesta G, Cacho J, Cucchiari D, Herrera S, Sempere A, Akter T, et al.
Infect Dis Ther
. 2024 May;
13(7):1703-1713.
PMID: 38789902
Introduction: There is no reliable microbiological marker to guide responses to antiviral treatment in kidney transplant recipients (KTR) with COVID-19. We aimed to evaluate the dynamics of subgenomic RNA (sgRNA)...
7.
Escudero-Saiz V, Gonzalez A, Garcia-Herrera A, Larque A, Bomback A, Morantes L, et al.
Kidney Med
. 2024 May;
6(6):100823.
PMID: 38741947
C3 glomerulopathy is a rare disease caused by fluid phase dysregulation of the alternative complement pathway. Currently, treatment depends on clinical and histological severity and includes nephroprotection, unspecific immunosuppression, and...
8.
Ugarte A, Bachero I, Cucchiari D, Sala M, Pereta I, Castells E, et al.
Ann Surg
. 2023 Dec;
279(5):727-733.
PMID: 38116685
Objective: To determine the feasibility and effectiveness of a Hospital at Home (HaH) enabled early transfer pathways for surgical patients. Background: HaH serves as a safe alternative to traditional hospitalization...
9.
Cucchiari D, Cuadrado-Payan E, Gonzalez-Roca E, Revuelta I, Argudo M, Ramirez-Bajo M, et al.
Nephrol Dial Transplant
. 2023 Sep;
39(1):114-121.
PMID: 37715343
Background: Ischemia-reperfusion injury (IRI) upon transplantation is one of the most impactful events that the kidney graft suffers during its life. Its clinical manifestation in the recipient, delayed graft function...
10.
Cuadrado-Payan E, Montagud-Marrahi E, Casals-Urquiza J, Del Risco-Zevallos J, Rodriguez-Espinosa D, Cacho J, et al.
Front Nephrol
. 2023 Sep;
2:1034182.
PMID: 37675023
Background: The age of patients referred for kidney transplantation has increased progressively. However, the precise influence of age on transplant outcomes is controversial. Methods: Etrospective study in which graft and...